CanSinoBIO

N/A

Report date: 2021/12/24 10:23:04

Base Information

Drug NameCanSinoBIO
Drug Alias NameCOVID 19 Vaccine(Aga Khan University Hospital)
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPakistan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAga Khan University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesAga Khan University Hospital
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A